Patrick Trojer, Triana Biomedicines CEO
December 3, 2025 10:28 AM EST
Updated 12:23 PM
FinancingStartups
Pfizer-allied molecular glue startup collects 20M Series B
Kyle LaHucik
Biotech Correspondent
Triana Biomedicines has reeled in a 20 million Series B — 0 million higher than its 2022 Series A …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER